More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$13.09B
EPS
8.17
P/E ratio
8.2
Price to sales
1.41
Dividend yield
--
Beta
0.746296
Previous close
$73.99
Today's open
$74.41
Day's range
$74.26 - $75.88
52 week range
$62.38 - $88.20
show more
CEO
Bryan C. Hanson
Employees
22000
Headquarters
Eagan, MN
Exchange
New York Stock Exchange
Shares outstanding
173174712
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Zacks Investment Research • Jun 9, 2026

Solventum Trends for 2026: AI Coding, Tariffs, and Margins
SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.
Zacks Investment Research • Jun 8, 2026

Solventum Corporation (SOLV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Solventum Corporation (SOLV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Jun 3, 2026

Solventum to Participate in the 2026 Jefferies Healthcare Conference
EAGAN, Minn., May 27, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, Jun. 3, 2026, beginning at approximately 9:55 a.m.
PRNewsWire • May 27, 2026

SOLV or HQY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • May 15, 2026

Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • May 13, 2026

Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.
Zacks Investment Research • May 12, 2026

Solventum to Participate in the 2026 BofA Securities Health Care Conference
ST. PAUL, Minn., May 7, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, beginning at approximately 10:00 a.m.
PRNewsWire • May 7, 2026

Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • May 7, 2026

Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Zacks Investment Research • May 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Solventum Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.